|
Name |
Methyl 12-methyltetradecanoate
|
Molecular Formula | C16H32O2 | |
IUPAC Name* |
methyl 12-methyltetradecanoate
|
|
SMILES |
CCC(C)CCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C16H32O2/c1-4-15(2)13-11-9-7-5-6-8-10-12-14-16(17)18-3/h15H,4-14H2,1-3H3
|
|
InChIKey |
BJIUDNXPLSJWKE-UHFFFAOYSA-N
|
|
Synonyms |
METHYL 12-METHYLTETRADECANOATE; 5129-66-8; Methyl 12-methylmyristate; 12-Methyltetradecanoic acid methyl ester; Tetradecanoic acid, 12-methyl-, methyl ester; METHYL12-METHYLTETRADECANOATE; SCHEMBL2499676; DTXSID20965581; methyl 12-methyl tetradeca-noate; Methyl tetradecanoate, 12-methyl; CHEBI:142658; 12-methylmyristic acid methyl ester; 2819F46C-BD79-404E-8476-D485872B5904
|
|
CAS | 5129-66-8 | |
PubChem CID | 21206 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 256.42 | ALogp: | 6.6 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 18 | QED Weighted: | 0.344 |
Caco-2 Permeability: | -4.624 | MDCK Permeability: | 0.00001640 |
Pgp-inhibitor: | 0.318 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.973 |
30% Bioavailability (F30%): | 0.975 |
Blood-Brain-Barrier Penetration (BBB): | 0.466 | Plasma Protein Binding (PPB): | 96.99% |
Volume Distribution (VD): | 1.126 | Fu: | 1.78% |
CYP1A2-inhibitor: | 0.892 | CYP1A2-substrate: | 0.305 |
CYP2C19-inhibitor: | 0.55 | CYP2C19-substrate: | 0.264 |
CYP2C9-inhibitor: | 0.462 | CYP2C9-substrate: | 0.907 |
CYP2D6-inhibitor: | 0.105 | CYP2D6-substrate: | 0.059 |
CYP3A4-inhibitor: | 0.466 | CYP3A4-substrate: | 0.116 |
Clearance (CL): | 6.319 | Half-life (T1/2): | 0.327 |
hERG Blockers: | 0.086 | Human Hepatotoxicity (H-HT): | 0.036 |
Drug-inuced Liver Injury (DILI): | 0.233 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.03 |
Skin Sensitization: | 0.949 | Carcinogencity: | 0.077 |
Eye Corrosion: | 0.941 | Eye Irritation: | 0.952 |
Respiratory Toxicity: | 0.899 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001142 | 0.893 | D0G2KD | 0.436 | ||||
ENC001519 | 0.786 | D05ATI | 0.426 | ||||
ENC000551 | 0.764 | D07ILQ | 0.410 | ||||
ENC000548 | 0.746 | D0P1RL | 0.407 | ||||
ENC000260 | 0.736 | D0Z5SM | 0.387 | ||||
ENC000495 | 0.727 | D0O1PH | 0.381 | ||||
ENC001160 | 0.710 | D05QNO | 0.380 | ||||
ENC000604 | 0.690 | D0Z5BC | 0.365 | ||||
ENC001274 | 0.685 | D09ANG | 0.363 | ||||
ENC000848 | 0.677 | D00MLW | 0.354 |